A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)

Overview of attention for article published in BMC Cancer, September 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 11,345 followers.

RT @radoncpapers: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for…

20 Feb 2020

Reply Repost Favourite

RT @radoncpapers: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for…

20 Feb 2020

Reply Repost Favourite

A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET). https://t.co/ovunSrXQXQ H/T @NCBI #radonc #PubMed

19 Feb 2020

Reply Repost Favourite

RT @FuenteApolo: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for p…

14 Oct 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.